FLOTEK INDUSTRIES INC (FTK)

US3433894090 - Common Stock

3.48  +0.02 (+0.58%)

After market: 3.75 +0.27 (+7.76%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to FTK. FTK was compared to 85 industry peers in the Chemicals industry. FTK has a medium profitability rating, but doesn't score so well on its financial health evaluation. FTK is valued correctly, but it does not seem to be growing.



4

1. Profitability

1.1 Basic Checks

In the past year FTK has reported negative net income.
FTK had a negative operating cash flow in the past year.
In the past 5 years FTK reported 4 times negative net income.
In the past 5 years FTK always reported negative operating cash flow.

1.2 Ratios

FTK has a Return On Assets of 15.68%. This is amongst the best in the industry. FTK outperforms 97.65% of its industry peers.
FTK's Return On Equity of 24.22% is amongst the best of the industry. FTK outperforms 91.76% of its industry peers.
Looking at the Return On Invested Capital, with a value of 15.56%, FTK belongs to the top of the industry, outperforming 94.12% of the companies in the same industry.
Industry RankSector Rank
ROA 15.68%
ROE 24.22%
ROIC 15.56%
ROA(3y)-23.58%
ROA(5y)-48.76%
ROE(3y)-584.56%
ROE(5y)-412.52%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

FTK's Profit Margin of 13.13% is amongst the best of the industry. FTK outperforms 85.88% of its industry peers.
FTK has a Operating Margin of 12.28%. This is in the better half of the industry: FTK outperforms 69.41% of its industry peers.
FTK has a Gross Margin of 12.91%. This is in the lower half of the industry: FTK underperforms 76.47% of its industry peers.
FTK's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 12.28%
PM (TTM) 13.13%
GM 12.91%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y4.97%

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), FTK is creating value.
The number of shares outstanding for FTK has been increased compared to 1 year ago.
The number of shares outstanding for FTK has been increased compared to 5 years ago.
Compared to 1 year ago, FTK has an improved debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 0.11, we must say that FTK is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.11, FTK is not doing good in the industry: 81.18% of the companies in the same industry are doing better.
FTK has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.07, FTK belongs to the top of the industry, outperforming 87.06% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Altman-Z 0.11
ROIC/WACC2.38
WACC6.55%

2.3 Liquidity

A Current Ratio of 1.60 indicates that FTK should not have too much problems paying its short term obligations.
FTK's Current ratio of 1.60 is on the low side compared to the rest of the industry. FTK is outperformed by 67.06% of its industry peers.
FTK has a Quick Ratio of 1.33. This is a normal value and indicates that FTK is financially healthy and should not expect problems in meeting its short term obligations.
FTK has a Quick ratio (1.33) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.6
Quick Ratio 1.33

3

3. Growth

3.1 Past

FTK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 96.61%, which is quite impressive.
The Revenue has grown by 38.17% in the past year. This is a very strong growth!
Measured over the past years, FTK shows a small growth in Revenue. The Revenue has been growing by 1.13% on average per year.
EPS 1Y (TTM)96.61%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q104.67%
Revenue 1Y (TTM)38.17%
Revenue growth 3Y52.43%
Revenue growth 5Y1.13%
Revenue growth Q2Q-12.47%

3.2 Future

FTK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 149.53% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y374.25%
EPS Next 2Y149.53%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year11.12%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for FTK. In the last year negative earnings were reported.
FTK is valuated reasonably with a Price/Forward Earnings ratio of 9.76.
Based on the Price/Forward Earnings ratio, FTK is valued cheaper than 96.47% of the companies in the same industry.
FTK's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.67.
Industry RankSector Rank
PE N/A
Fwd PE 9.76

4.2 Price Multiples

FTK's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. FTK is cheaper than 92.94% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.1

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
FTK's earnings are expected to grow with 149.53% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y149.53%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for FTK!.
Industry RankSector Rank
Dividend Yield N/A

FLOTEK INDUSTRIES INC

NYSE:FTK (4/24/2024, 7:04:07 PM)

After market: 3.75 +0.27 (+7.76%)

3.48

+0.02 (+0.58%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap103.22M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 9.76
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 15.68%
ROE 24.22%
ROCE
ROIC
ROICexc
ROICexgc
OM 12.28%
PM (TTM) 13.13%
GM 12.91%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.19
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.6
Quick Ratio 1.33
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)96.61%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y374.25%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)38.17%
Revenue growth 3Y52.43%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y